The phosphorylation of AT8 site induces a conformational change of Tau marked at AT100 which has been identified with inhibition of replication [92], rDNA transcriptional inactivation [93] and the preservation of this population of vulnerable AD neurons in G0 [89]. Here, MAPT is linked to Alzheimer disease.